These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22728220)

  • 1. The feasibility of identifying children with primary immunodeficiency disorders: preparation for the polio post-eradication era in Bangladesh.
    Sazzad HM; Rainey JJ; Mach O; Sutter R; Diordista S; Kawser CA; Mobarak R; Alam D; Chowdhury MA; Hossain MJ; Hasan AS; Luby SP
    Vaccine; 2012 Aug; 30(36):5396-400. PubMed ID: 22728220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for long-term poliovirus excretion among children with primary immunodeficiency disorders: preparation for the polio posteradication era in Bangladesh.
    Sazzad HM; Rainey JJ; Kahn AL; Mach O; Liyanage JB; Alam AN; Kawser CA; Hossain A; Sutter R; Luby SP
    J Infect Dis; 2014 Nov; 210 Suppl 1():S373-9. PubMed ID: 25316858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka.
    de Silva R; Gunasena S; Ratnayake D; Wickremesinghe GD; Kumarasiri CD; Pushpakumara BA; Deshpande J; Kahn AL; Sutter RW
    Vaccine; 2012 Dec; 30(52):7561-5. PubMed ID: 23099333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Shaghaghi M; Soleyman-Jahi S; Abolhassani H; Yazdani R; Azizi G; Rezaei N; Barbouche MR; McKinlay MA; Aghamohammadi A
    Vaccine; 2018 Mar; 36(13):1711-1719. PubMed ID: 29478755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.
    Duintjer Tebbens RJ; Pallansch MA; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():379. PubMed ID: 26382043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019.
    Macklin G; Diop OM; Humayun A; Shahmahmoodi S; El-Sayed ZA; Triki H; Rey G; Avagyan T; Grabovac V; Jorba J; Farag N; Mach O
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(28):913-917. PubMed ID: 32673297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.
    Guo J; Bolivar-Wagers S; Srinivas N; Holubar M; Maldonado Y
    Vaccine; 2015 Mar; 33(10):1235-42. PubMed ID: 25600519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients.
    McDonald SL; Weldon WC; Wei L; Chen Q; Shaw J; Zhao K; Jorba J; Kew OM; Pallansch MA; Burns CC; Steven Oberste M
    Vaccine; 2020 Mar; 38(14):3042-3049. PubMed ID: 32089462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
    Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
    Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to detect infection by oral polio vaccine virus following natural exposure among inactivated polio vaccine recipients.
    Gary HE; Smith B; Jenks J; Ruiz J; Sessions W; Vinje J; Sobsey M
    Epidemiol Infect; 2008 Feb; 136(2):180-3. PubMed ID: 17376256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():741-6. PubMed ID: 22992572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
    Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
    Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Universal use of inactivated poliovirus vaccine--the needs and challenges].
    Shimizu H; Takeda N
    Nihon Rinsho; 2008 Oct; 66(10):1950-5. PubMed ID: 18939495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.